GT Medical Technologies has appointed Tom Moore as chief commercial officer and Sandeep Yadav as chief financial officer.
Moore has more than two decades of experience in healthcare, having started his medtech career at Medtronic. Prior to joining GT MedTech, he was on the executive leadership teams at CVRx and Ablative Solutions.
“GammaTile has one of the most compelling stories for its impact on patients suffering from new and recurrent brain tumors,” Moore said in a news release. “I look forward to working closely with the leadership team to bring GammaTile to reach its full potential as we expand our reach beyond the more than 1,400 patients already treated.”
Yadav has over two decades of experience in finance, data analytics, operations and strategic leadership. He has held senior roles at CardioMEMS, Qardio, Profusa and Cardian.
“I am thrilled to join GT Medical Technologies at this pivotal moment in its journey. The innovative work being done with GammaTile has the potential to revolutionize the treatment of brain tumors and significantly improve patient outcomes,” Yadav said. “I am excited to work with the talented professionals at GT Medical Technologies to drive our mission forward and achieve groundbreaking advancements in medical technology.”
GT Medical makes the GammaTile device, an FDA-cleared treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms.
“We’re thrilled to add two well-respected leaders with Tom and Sandeep to our senior leadership team,” said Per Langoe, CEO of GT MedTech. “Tom’s ability to develop effective commercial strategies will help accelerate the adoption of GammaTile across the country, while Sandeep’s expertise in our industry will ensure the company’s financial health and continued growth.”
